本页面由Tiger Trade Technology Pte. Ltd.提供服务

福泰制药

477.92
+19.114.17%
盘后475.01-2.9100-0.61%19:43 EST
成交量:162.17万
成交额:7.68亿
市值:1,212.57亿
市盈率:33.60
高:478.28
开:459.69
低:459.00
收:458.81
52周最高:519.68
52周最低:362.50
股本:2.54亿
流通股本:2.54亿
量比:1.34
换手率:0.64%
股息:- -
股息率:- -
每股收益(TTM):14.22
每股收益(LYR):-2.0768
净资产收益率:22.31%
总资产收益率:12.04%
市净率:7.00
市盈率(LYR):-230.13

数据加载中...

2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/04

重要事件披露

Form 8-K - Current report
2025/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/05

重要事件披露

Form 8-K - Current report
2025/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/19

重要事件披露

Form 8-K - Current report